Autoimmune kidney disease and lymphadenopathy in NOD lpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or  2 -microglobulin

Author： Catterall T.  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.15, Iss.6, 2003-06, pp. : 679-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis

By Wang H-B.  

International Immunology, Vol. 12, Iss. 10, 2000-10 ,pp. : 1381-1388

Oxford University Press

Access to resources Recommend Favorite

Tumor necrosis factor and autoimmune disease: the other side of the coin

By Gurwitz D.  

Trends in Molecular Medicine, Vol. 7, Iss. 4, 2001-04 ,pp. : 148-149

Elsevier

Access to resources Recommend Favorite

Iodine-Induced Autoimmune Thyroiditis in NOD-H-2 h4 Mice

By Rasooly L.   Burek C.L.   Rose N.R.  

Clinical Immunology, Vol. 81, Iss. 3, 1996-12 ,pp. : 287-292

Academic Press

Access to resources Recommend Favorite

Immunobiology of tumor necrosis factor receptor superfamily

By Zhou Tong   Mountz John   Kimberly Robert  

Immunologic Research, Vol. 26, Iss. 1-3, 2002-12 ,pp. : 323-336

Humana Press, Inc

Access to resources Recommend Favorite

An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/ 2-microglobulin null mice

By Ishikawa F.   Livingston A.G.   Wingard J.R.   Nishikawa S.-i.   Ogawa M.  

Experimental Hematology, Vol. 30, Iss. 5, 2002-05 ,pp. : 488-494

Elsevier

Access to resources Recommend Favorite